87 related articles for article (PubMed ID: 15599614)
1. Studies on homocysteine plasma levels in Alzheimer's patients. Relevance for neurodegeneration.
Agnati LF; Genedani S; Rasio G; Galantucci M; Saltini S; Filaferro M; Franco R; Mora F; Ferré S; Fuxe K
J Neural Transm (Vienna); 2005 Jan; 112(1):163-9. PubMed ID: 15599614
[TBL] [Abstract][Full Text] [Related]
2. Plasma homocysteine in Alzheimer's disease with or without co-morbid depressive symptoms.
Kitzlerová E; Fisar Z; Jirák R; Zvĕrová M; Hroudová J; Benaková H; Raboch J
Neuro Endocrinol Lett; 2014; 35(1):42-9. PubMed ID: 24625917
[TBL] [Abstract][Full Text] [Related]
3. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
4. Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients.
Genedani S; Rasio G; Cortelli P; Antonelli F; Guidolin D; Galantucci M; Fuxe K; Agnati LF
Neurotox Res; 2004; 6(4):327-32. PubMed ID: 15545016
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine may contribute to pathogenesis of RNA damage in brains with Alzheimer's disease.
Isobe C; Abe T; Terayama Y
Neurodegener Dis; 2009; 6(5-6):252-7. PubMed ID: 19940460
[TBL] [Abstract][Full Text] [Related]
6. Plasma homocysteine levels are not increased in murine models of Alzheimer's disease.
Santiard-Baron D; Aupetit J; Janel N
Neurosci Res; 2005 Dec; 53(4):447-9. PubMed ID: 16213620
[TBL] [Abstract][Full Text] [Related]
7. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
[TBL] [Abstract][Full Text] [Related]
8. Increased homocysteine and decreased adenosine formation in Alzheimer's disease.
Selley ML
Neurol Res; 2004 Jul; 26(5):554-7. PubMed ID: 15265273
[TBL] [Abstract][Full Text] [Related]
9. Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease.
Arlt S; Schwedhelm E; Kölsch H; Jahn H; Linnebank M; Smulders Y; Jessen F; Böger RH; Popp J
J Alzheimers Dis; 2012; 31(4):751-8. PubMed ID: 22710910
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
Oulhaj A; Refsum H; Beaumont H; Williams J; King E; Jacoby R; Smith AD
Int J Geriatr Psychiatry; 2010 Jan; 25(1):82-90. PubMed ID: 19484711
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory cytokines IL-1β and TNF-α are not associated with plasma homocysteine concentration in Alzheimer's disease.
Veryard L; Jones E; Weaving G; Smith E; Cheek L; Wickramasinghe A; Tabet N
Curr Alzheimer Res; 2013 Feb; 10(2):174-9. PubMed ID: 23463936
[TBL] [Abstract][Full Text] [Related]
12. Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study.
Smach MA; Jacob N; Golmard JL; Charfeddine B; Lammouchi T; Ben Othman L; Dridi H; Bennamou S; Limem K
Eur Neurol; 2011; 65(5):270-8. PubMed ID: 21474939
[TBL] [Abstract][Full Text] [Related]
13. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T
Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827
[TBL] [Abstract][Full Text] [Related]
14. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
[TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel.
Mizrahi EH; Bowirrat A; Jacobsen DW; Korczyn AD; Traore F; Petot GJ; Lerner AJ; Debanne SM; Adunsky A; Dibello PM; Friedland RP
J Neurol Sci; 2004 Dec; 227(1):109-13. PubMed ID: 15546600
[TBL] [Abstract][Full Text] [Related]
16. Behavioural and psychological symptoms of Alzheimer type dementia are not correlated with plasma homocysteine concentration.
Tabet N; Rafi H; Weaving G; Lyons B; Iversen SA
Dement Geriatr Cogn Disord; 2006; 22(5-6):432-8. PubMed ID: 16983185
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease.
Nilsson K; Gustafson L; Hultberg B
Int J Geriatr Psychiatry; 2004 Jul; 19(7):666-72. PubMed ID: 15254923
[TBL] [Abstract][Full Text] [Related]
18. Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease.
Hasegawa T; Ukai W; Jo DG; Xu X; Mattson MP; Nakagawa M; Araki W; Saito T; Yamada T
J Neurosci Res; 2005 Jun; 80(6):869-76. PubMed ID: 15898106
[TBL] [Abstract][Full Text] [Related]
19. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer's disease.
Boldyrev AA; Johnson P
J Alzheimers Dis; 2007 May; 11(2):219-28. PubMed ID: 17522446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
